Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients

Immunol Rev. 2005 Feb:203:110-26. doi: 10.1111/j.0105-2896.2005.00234.x.

Abstract

Analysis of gene-targeted mice and patients with severe combined immunodeficiency due to mutations of the alpha chain of the interleukin-7 receptor (IL-7Ralpha) has shown important differences between mice and humans in the role played by IL-7 in lymphoid development. More recently, it has been shown that IL-7Ralpha is also shared by the receptor for another cytokine, thymic stromal lymphopoietin (TSLP). In this review, we discuss recent advances in IL-7- and TSLP-mediated signaling. We also report on the clinical and immunological features of 16 novel patients with IL-7Ralpha deficiency and discuss the results of hematopoietic stem cell transplantation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • B-Lymphocytes / immunology
  • Cytokines / genetics
  • Cytokines / immunology
  • Female
  • Humans
  • Male
  • Mice
  • Molecular Sequence Data
  • Mutation / genetics
  • Receptors, Interleukin-7 / chemistry
  • Receptors, Interleukin-7 / deficiency*
  • Receptors, Interleukin-7 / genetics
  • Severe Combined Immunodeficiency / diagnosis
  • Severe Combined Immunodeficiency / genetics*
  • Severe Combined Immunodeficiency / immunology*
  • Signal Transduction
  • T-Lymphocytes / immunology
  • Thymic Stromal Lymphopoietin

Substances

  • Cytokines
  • Receptors, Interleukin-7
  • interleukin-7 receptor, alpha chain
  • Thymic Stromal Lymphopoietin